|
E-baseDrug - E-base The trade name of the product as shown on the labeling.
Dosage -
TABLET, DELAYED RELEASE; ORAL
Active Ingredient(s) -
Erythromycin
Strength -
333MG
Applicant -
BARR
New Drug Application (NDA) Number -
063086
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
May 15, 1990
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Barr Laboratories Inc
E-base
Pce 333mg Tablet, Coated Particles; Oral
Pce 500mg Tablet, Coated Particles; Oral E-base 333mg Tablet, Delayed Release; Oral E-base 333mg Tablet, Delayed Release; Oral T-stat 2% Solution; Topical C-solve-2 2% Swab; Topical Erycette 2% Swab; Topical Erythromycin 2% Swab; Topical Erythromycin 2% Swab; Topical T-stat 2% Swab; Topical NewDrugInformation |